Related Experiment Video
Updated: Oct 29, 2025

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
Inter-kingdom relationships in Crohn's disease explored using a multi-omics approach
Alessandra Frau1, Umer Z Ijaz2, Rachael Slater1
1Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
Bacterial and fungal dysbiosis, particularly involving Bacteroides and Candida, are linked to Crohn's disease (CD). Understanding these microbial interactions offers new insights for CD development and treatment strategies.
Area of Science:
- Gastroenterology
- Microbiology
- Immunology
Background:
- The etiology of Crohn's disease (CD) is multifactorial, involving both bacterial and fungal microbiota.
- While bacterial dysbiosis in CD is recognized, the role of the mycobiome and its interplay with bacteria remains less understood.
- Investigating interkingdom relationships and metabolic consequences is crucial for understanding CD pathogenesis.
Purpose of the Study:
- To investigate interkingdom relationships between bacteria and fungi in Crohn's disease.
- To explore the metabolic consequences of these microbial interactions.
- To analyze changes in the fungal community during CD relapse and remission.
Main Methods:
- Analysis of fungal and bacterial communities in biopsy and fecal samples from two cohorts (British and Dutch).
- Fecal volatile analysis and dataset integration.
- Longitudinal analysis of the gut mycobiome stability in CD patients.
Main Results:
- Observed bacterial dysbiosis in both biopsies and stool samples.
- Bacteroides may play a key role in CD, potentially modulating Candida colonization.
- Fungal dysbiosis was noted in the Dutch cohort, with increased Malassezia and Candida in patients on immunosuppressants; Cyberlindnera increased during relapse.
- Saccharomyces dominated fecal samples, but not biopsies.
- Amino acid degradation was the primary metabolic alteration in CD, implicating both bacterial and fungal communities.
Conclusions:
- Bacteroides and yeasts are implicated in Crohn's disease.
- Understanding the role and relationship between these microbes can provide new perspectives on CD development.
- This research highlights potential therapeutic targets for Crohn's disease.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Genomics
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

